← Back to Search

Dementia care management for Dementia (SMPES Trial)

N/A
Waitlist Available
Led By Joshua Chodosh, MD, MSHS
Research Sponsored by VA Greater Los Angeles Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria: Health plan member eligibility includes having a visit-based ICD-9 diagnostic code for dementia or a dementia-specific medication (including donepezil, rivastigmine, galantamine, and memantine) within administrative data any time prior to data inquiry for potential subjects. The health plan member must have a caregiver who can communicate by telephone and though that person might also be a health plan member, health plan membership for caregivers is not required. All subjects must be living in the community and if in a nursing facility, this must be for rehabilitation or respite care but not for long term care. Caregivers must be able to communicate in English or Spanish.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 and 18 months
Awards & highlights

SMPES Trial Summary

The SCAN Memory Program Evaluation study is an evaluation of a randomized controlled trial intervention consisting of a care management program for cognitively-impaired health plan members and for their informal/family caregivers. The program includes collaboration between the health plan, partnering medical groups, and community organizations. Program activities include: 1) telephonic-structured assessments with informal caregivers conducted by SCAN Memory Program care managers; 2) problem identification as a result of these assessments; and 3) pre-established protocols and procedures for problem resolution. ACCESS, the prototype for the SCAN Memory Program, was developed and tested in San Diego County and was very successful in helping affected patients and their caregivers.

SMPES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SMPES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Guideline Adherence
Healthcare utilization
Program feasibility and fidelity
Secondary outcome measures
Behavioral disturbance
Caregiver burden
Mental Depression
+6 more

SMPES Trial Design

2Treatment groups
Active Control
Group I: Usual careActive Control1 Intervention
Patients and care family care givers will receive usual support and medical care offered by the health plan.
Group II: Dementia care managementActive Control1 Intervention
Patients and family caregivers will be offered dementia care management, which includes detailed comprehensive assessment, education, counseling, referrals to community agencies, collaboration with medical providers and frequent telephone follow-up

Find a Location

Who is running the clinical trial?

University of California, Los AngelesOTHER
1,528 Previous Clinical Trials
10,276,351 Total Patients Enrolled
13 Trials studying Dementia
6,850 Patients Enrolled for Dementia
VA Greater Los Angeles Healthcare SystemLead Sponsor
51 Previous Clinical Trials
8,069 Total Patients Enrolled
2 Trials studying Dementia
540 Patients Enrolled for Dementia
Joshua Chodosh, MD, MSHSPrincipal InvestigatorVA / UCLA

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~32 spots leftby Apr 2025